Comparison of Analgesic Efficacy of Quadratus Lumborum Type 3 and Suprainguinal Fascia Iliaca Compartment Block in Total Hip Arthroplasty Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-15

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Total Hip Arthroplasty (THA) is a complex surgical procedure frequently performed to treat degenerative conditions in the hip joint. As people's life expectancy increases, the need for hip arthroplasty increases. İnvestigetors aimed to compare the analgesic properties of SIFI and QLB blocks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Postoperative Analgesia in Hip Arthroplasty

NCT07153575

Hip Fractures Post Operative Pain Postoperative Nausea and Vomiting

ACTIVE_NOT_RECRUITING NA

Comparison of QIPB and SIFICB in Hip Surgery

NCT07233746

Postoperative Pain Hip Surgery

NOT_YET_RECRUITING NA

Effect of Quadro-Iliac Plane Block on Recovery After Total Hip Arthroplasty

NCT06870071

Postoperative Pain

COMPLETED NA

SFIB vs Anterior QLB in Total Hip Arthroplasty

NCT05684471

Pain

COMPLETED NA

Comparison of Sacral Erector Spinae Plane Block and Supra-Inguinal Fascia Iliaca Block for Analgesia After Hip Fracture Surgery

NCT07081867

Hip Fracture Surgery Postoperative Pain Management Regional Anesthesia +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Consumption Pain Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SIFI Group

Group of 30 patients who underwent SIFI block

Group Type ACTIVE_COMPARATOR

Bupivacain

Intervention Type DRUG

Suprainguinal Fascia Iliaca Compartment block was performed with a linear probe placed over the inguinal ligament using a portable ultrasound device. After visualization of the femoral nerve, 30 ml of 0.25% bupivacaine was injected into the fascia iliaca overlying the iliopsoas muscle using an appropriate needle.

QLB Type 3

Group of 30 patients who underwent QLB block

Group Type ACTIVE_COMPARATOR

Bupivacain

Intervention Type DRUG

Quadratus Lumborum Type 3 block was performed using a portable ultrasound device with a linear probe placed between the costal margin and the iliac crest on the lateral abdominal wall. 30 ml of 0.25% bupivacaine was injected between the quadratus lumborum and psoas muscles using an appropriate needle.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacain

Suprainguinal Fascia Iliaca Compartment block was performed with a linear probe placed over the inguinal ligament using a portable ultrasound device. After visualization of the femoral nerve, 30 ml of 0.25% bupivacaine was injected into the fascia iliaca overlying the iliopsoas muscle using an appropriate needle.

Intervention Type DRUG

Bupivacain

Quadratus Lumborum Type 3 block was performed using a portable ultrasound device with a linear probe placed between the costal margin and the iliac crest on the lateral abdominal wall. 30 ml of 0.25% bupivacaine was injected between the quadratus lumborum and psoas muscles using an appropriate needle.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SIFI QLB Type 3

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Elective patients scheduled for hip arthroplasty surgery
2. Patient willingness to participate in the study
3. Patients over 18 years age of, ASA I-II-III,

Exclusion Criteria

1. Patients not wanting to participate in the study
2. Patients who do not want regional anesthesia technique
3. Allergic or coagulated patients
4. Patients with liver, kidney, lung, heart failure and septic patients
5. Neurological disorder, history of convulsions
6. ASA IV patients

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes